Invesco Dorsey Wright Emerging Markets Momentum ETF

PIE

Market cap $225M

The U.S. ​Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency said could cut years from drug approval timelines and keep the U.S. competitive with China.

The Invesco Dorsey Wright Emerging Markets Momentum ETF targets high relative strength stocks, with a heavy tilt toward Taiwan and technology. Despite a recent rally, PIE has underperformed EEM since inception, with higher volatility and drawdowns. Multi-factor ETFs like AVEM, FNDE, and EMGF offer better fees, liquidity, and risk-adjusted returns than PIE for emerging markets exposure.